V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220012443 | 220006908 | 1.66 | 88.8 | Palliative (P) | 2015-10-30 | 2015-12-14 | AML17 TRIAL | null | N | 220026487 | AML17 TRIAL |
| 220012444 | 220006909 | 1.5 | 80.8 | Curative (C) | null | 2016-02-04 | FLAG + Idarubicin | Y | N | 220026487 | FLAG + IDARUBICIN |
| 220012445 | 220006909 | 1.58 | 80.2 | Palliative (P) | 2016-07-03 | 2016-07-05 | FLAG + Idarubicin | 2 | N | 220026487 | FLAG + IDARUBICIN |
| 220012447 | 220006911 | 1.61 | 64 | Curative (C) | 2013-02-21 | 2013-04-04 | AML17 TRIAL | 02 | N | 220026504 | AML17 TRIAL |
| 220012448 | 220006912 | 1.6 | 70.7 | Curative (C) | 2017-08-17 | 2017-08-18 | FLAG + Idarubicin | 02 | N | 220026504 | FLAG + IDARUBICIN |
| 220012449 | 220006912 | 1.85 | 98.4 | Curative (C) | 2017-11-12 | 2017-11-20 | FLAG + Idarubicin | Y | N | 220026504 | FLAG + IDARUBICIN |
| 220012450 | 220006913 | 1.75 | 70.5 | Curative (C) | 2015-12-01 | 2015-12-02 | AML17 TRIAL | 02 | N | 220026511 | AML17 TRIAL |
| 220012451 | 220006914 | 1.78 | 75.1 | Curative (C) | 2013-07-03 | 2013-08-28 | FLAG + Idarubicin | 01 | N | 220026512 | FLAG + IDARUBICIN |
| 220012452 | 220006914 | 1.87 | 120 | Curative (C) | 2013-07-03 | 2013-07-10 | AML17 TRIAL | N | N | 220026512 | AML17 TRIAL |
| 220012453 | 220006914 | 0 | 66.7 | Curative (C) | 2016-10-24 | 2016-10-24 | AML17 TRIAL | N | N | 220026512 | AML17 TRIAL |
| 220012454 | 220006915 | 1.7 | null | Curative (C) | null | 2017-08-20 | FLAG + Idarubicin | 2 | null | 220026530 | FLAG + IDARUBICIN |
| 220012455 | 220017522 | 1.72 | 83 | Curative (C) | 2013-12-23 | 2013-12-23 | AML Interim Guidelines FLAG-Ida | Y | null | 220026533 | FLAG + IDARUBICIN |
| 220012456 | 220019606 | null | 55.3 | null | 2014-12-12 | 2015-01-19 | FLAG + Idarubicin | Y | N | 220026533 | FLAG + IDARUBICIN |
| 220012457 | 220019606 | 1.56 | 68.2 | Disease modification (D) | 2015-11-19 | 2015-12-24 | AML17 TRIAL | N | N | 220026533 | AML17 TRIAL |
| 220012458 | 220019606 | 1.5 | 47 | Curative (C) | 2018-02-14 | 2018-03-28 | AML17 TRIAL | Y | N | 220026533 | AML17 TRIAL |
| 220012459 | 220019606 | 1.73 | 97 | Curative (C) | 2013-01-27 | 2013-03-04 | AML17 TRIAL | Y | N | 220026533 | AML17 TRIAL |
| 220012460 | 220006917 | 1.88 | 69.499 | Curative (C) | 2014-08-20 | 2014-09-19 | AML17 TRIAL | Y | N | 220026565 | AML17 TRIAL |
| 220012461 | 220013817 | 1.72 | 56.7 | Curative (C) | 2017-02-23 | 2017-03-30 | AML17 TRIAL | Y | N | 220026567 | AML17 TRIAL |
| 220012462 | 220006922 | 1.85 | 80 | Curative (C) | null | 2017-07-25 | AML17 TRIAL | 01 | N | 220026573 | AML17 TRIAL |
| 220012463 | 220006922 | 1.82 | 121.5 | Curative (C) | 2013-06-25 | 2013-08-03 | FLAG + Idarubicin | Y | N | 220026573 | FLAG + IDARUBICIN |
| 220012466 | 220006927 | 1.74 | 118.8 | Palliative (P) | 2016-10-31 | 2017-02-20 | FLAG + Idarubicin | 2 | N | 220026587 | FLAG + IDARUBICIN |
| 220012467 | 220006931 | 1.82 | 70.8 | Adjuvant (A) | 2016-06-09 | 2016-07-16 | FLAG + Idarubicin | N | N | 220026587 | FLAG + IDARUBICIN |
| 220012468 | 220006931 | 1.66 | 75.2 | Adjuvant (A) | 2014-05-08 | 2014-07-11 | FLAG + Idarubicin | null | N | 220026587 | FLAG + IDARUBICIN |
| 220012469 | 220006932 | 0 | 79 | Curative (C) | 2014-08-25 | 2014-08-26 | FLAG + Idarubicin | 2 | N | 220026595 | FLAG + IDARUBICIN |
| 220012470 | 220006933 | 1.68 | null | Radical (R) | 2016-11-07 | 2016-11-07 | AML17 TRIAL | N | N | 220026598 | AML17 TRIAL |
| 220012471 | 220006933 | 1.52 | 67.5 | Radical (R) | null | 2016-02-16 | AML17 TRIAL | null | N | 220026598 | AML17 TRIAL |
| 220012472 | 220006934 | 1.84 | 141 | Adjuvant (A) | 2017-01-22 | 2017-04-06 | FLAG + Idarubicin | N | null | 220026609 | FLAG + IDARUBICIN |
| 220012473 | 220006937 | 1.75 | 54.5 | Curative (C) | null | 2017-09-23 | FLAG + Idarubicin | 1 | null | 220026612 | FLAG + IDARUBICIN |
| 220012474 | 220006940 | 1.77 | 87.7 | Curative (C) | 2014-02-28 | 2015-03-27 | AML Interim Guidelines FLAG-Ida | 01 | N | 220026614 | FLAG + IDARUBICIN |
| 220012475 | 220006941 | 1.62 | 62.4 | Disease modification (D) | null | 2016-06-03 | AML17 TRIAL | Y | N | 220026614 | AML17 TRIAL |
| 220012476 | 220006942 | 1.63 | 46.9 | Curative (C) | 2013-06-29 | 2013-08-21 | AML17 TRIAL | N | N | 220026621 | AML17 TRIAL |
| 220012477 | 220006944 | 1.7 | 101 | Curative (C) | null | 2018-02-12 | FLAG + Idarubicin | Y | Y | 220026628 | FLAG + IDARUBICIN |
| 220012479 | 220006946 | 1.67 | 51.3 | Curative (C) | 2014-11-05 | 2014-11-05 | AML17 TRIAL | 02 | N | 220026635 | AML17 TRIAL |
| 220012480 | 220013829 | 1.85 | 74.8 | Not known (9) | 2014-06-04 | 2014-07-11 | AML17 TRIAL | Y | N | 220026636 | AML17 TRIAL |
| 220012481 | 220006950 | 1.61 | 88.8 | Curative (C) | 2014-03-13 | 2014-04-14 | AML17 TRIAL | Y | N | 220026641 | AML17 TRIAL |
| 220012482 | 220006952 | 1.95 | 97.5 | Curative (C) | 2016-11-03 | 2017-02-07 | AML17 TRIAL | Y | N | 220026660 | AML17 TRIAL |
| 220012483 | 220006952 | 1.85 | 76.4 | Curative (C) | 2014-01-17 | 2014-01-17 | FLAG + Idarubicin | Y | N | 220026660 | FLAG + IDARUBICIN |
| 220012484 | 220006953 | 1.63 | 93.1 | Curative (C) | null | 2016-04-03 | AML17 TRIAL | 2 | N | 220026663 | AML17 TRIAL |
| 220012485 | 220006955 | 1.52 | 52.2 | Disease modification (D) | 2019-04-15 | 2019-04-15 | AML17 TRIAL | N | N | 220026675 | AML17 TRIAL |
| 220012486 | 220006957 | 1.9 | 105.3 | Curative (C) | 2016-03-22 | 2016-05-07 | FLAG + Idarubicin | Y | N | 220026681 | FLAG + IDARUBICIN |
| 220012487 | 220006960 | null | 54 | Curative (C) | 2013-05-07 | 2013-06-05 | AML17 TRIAL | Y | null | 220026683 | AML17 TRIAL |
| 220012488 | 220006960 | 1.5 | 60.8 | Curative (C) | 2017-12-13 | 2017-12-14 | AML17 TRIAL | N | N | 220026683 | AML17 TRIAL |
| 220012489 | 220006960 | null | 71.4 | Unknown (U) | 2015-10-01 | 2015-11-22 | AML17 TRIAL | Y | N | 220026683 | AML17 TRIAL |
| 220012490 | 220006960 | 1.72 | 53.3 | Curative (C) | 2014-05-06 | 2014-05-06 | AML17 TRIAL | 02 | N | 220026683 | AML17 TRIAL |
| 220012491 | 220006961 | 1.78 | 124 | null | 2013-08-14 | 2013-08-18 | AML17 TRIAL | N | N | 220026693 | AML17 TRIAL |
| 220012492 | 220013836 | 1.84 | 63.4 | Curative (C) | null | 2017-12-24 | FLAG + Idarubicin | Y | N | 220026694 | FLAG + IDARUBICIN |
| 220012493 | 220006964 | 1.67 | 62.6 | Adjuvant (A) | 2016-04-02 | 2016-04-03 | AML17 TRIAL | 02 | N | 220026698 | AML17 TRIAL |
| 220012494 | 220017532 | 1.69 | 120 | Curative (C) | 2013-10-21 | 2013-10-21 | AML17 TRIAL | Y | N | 220026699 | AML17 TRIAL |
| 220012495 | 220006965 | 1.7 | null | Curative (C) | null | 2015-02-18 | AML17 TRIAL | 1 | null | 220026700 | AML17 TRIAL |
| 220012496 | 220019608 | 1.6 | 83.4 | Curative (C) | 2017-08-04 | 2017-08-04 | AML17 TRIAL | 1 | N | 220026704 | AML17 TRIAL |